Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT02259738

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
XuanwuH 2 (from the registry)
Registry
  • NCT NCT02259738
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02259738. Allocation not applicable; single masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2014-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase
Condition
Cerebral Infarction
Intervention (Drug)
Human Urinary Kallidinogenase
Intervention (Drug)
Shuxuening injection
Lead sponsor
XuanwuH 2 (class: other)

Record details

Record id
cardio:ct-nct02259738
Content hash
8b8e355b8d159ac9e8d9a8a3914827fc685947ff5804e0c0b8ed98000b56e673